{"organizations": [], "uuid": "8ecfc95a79a7abb1df8259629f2dad68da3e6c7c", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources/r/?m=02&d=20180412&t=2&i=1250673680&w=1200&r=LYNXMPEE3B0SR", "site_section": "https://www.reuters.com/finance/EarningsUS", "section_title": "Earnings News &amp; Latest Company Earnings Results | Reuters.com", "url": "https://www.reuters.com/article/us-rite-aid-corp-results/drug-retailer-rite-aids-revenue-misses-estimates-idUSKBN1HJ1LO", "country": "US", "domain_rank": 408, "title": "Drug retailer Rite Aid's revenue misses estimates", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.184, "site_type": "news", "published": "2018-04-12T19:15:00.000+03:00", "replies_count": 0, "uuid": "8ecfc95a79a7abb1df8259629f2dad68da3e6c7c"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/us-rite-aid-corp-results/drug-retailer-rite-aids-revenue-misses-estimates-idUSKBN1HJ1LO", "ord_in_thread": 0, "title": "Drug retailer Rite Aid's revenue misses estimates", "locations": [], "entities": {"persons": [{"name": "vibhuti sharma", "sentiment": "none"}, {"name": "sriraj kalluvila", "sentiment": "none"}, {"name": "saumyadeb chakrabarty", "sentiment": "none"}], "locations": [{"name": "u.s.", "sentiment": "none"}, {"name": "bengaluru", "sentiment": "none"}, {"name": "massachusetts", "sentiment": "none"}, {"name": "somerville", "sentiment": "none"}], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "albertsons cos", "sentiment": "negative"}, {"name": "thomson reuters", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": " 15 AM / a few seconds ago Drug retailer Rite Aid's revenue misses estimates Reuters Staff 1 Min Read \n(Reuters) - Drug retailer Rite Aid ( RAD.N ), which is being bought by U.S. grocer Albertsons Cos Inc, posted smaller-than-expected fourth-quarter revenue, hurt by a decline in reimbursement rates and prescription volumes. FILE PHOTO: A sign marks a Rite Aid pharmacy in Somerville, Massachusetts, U.S., June 29, 2017. REUTERS/Brian Snyder/File Photo \nRevenue fell to $5.39 billion from $5.90 billion, missing the average analyst estimate of $5.57 billion, according to Thomson Reuters I/B/E/S. \nThe company posted net loss from continuing operations of $483.7 million, or 46 cents per share, for the quarter ended March 3, compared with a loss of $25.1 million, or 2 cents per share, a year earlier. \nThe loss includes $325 million of income tax expense related mainly to the revaluation of the companyâ€™s deferred tax assets in connection with the new U.S. tax law. \nExcluding one-time items, Rite Aid reported a loss of 1 cent per share. Reporting by Vibhuti Sharma in Bengaluru; Editing by Sriraj Kalluvila and Saumyadeb Chakrabarty", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-04-12T19:15:00.000+03:00", "crawled": "2018-04-12T14:27:21.003+03:00", "highlightTitle": ""}